Last deal

$1.01M

Amount

Debt Financing

Stage

29.09.2020

Date

3

all rounds

$8.09M

Total amount

date founded

Financing round

General

About Company
Tetragenetics offers a cost-effective alternative platform technology for genetically engineered protein production.

Industry

Sector :

Subsector :

Keywords :

founded date

01.01.2004

founders

Number of employees

Company Type

For Profit

Last funding type

Debt Financing

IPO status

Private

Description

The early-stage biotech company specializes in producing eucaryotic membrane and secretory proteins that are difficult to express in conventional systems, such as vaccine antigens, monoclonal antibodies, and therapeutic proteins for human and animal disease treatment and prevention. Their bio-pharmaceutical platform uses Tetrahymena thermophila to produce large quantities of properly folded, functional transmembrane proteins, which are challenging to express using conventional systems. This empowers antibody discovery against difficult-to-drug targets and provides physicians with treatments for ion channel-related autoimmune diseases and pain management.
Contacts

Contact Email

Phone number

Social url

Similar Companies
1000
T3S Technologies

T3S Technologies

T3S Technologies offers a groundbreaking protein expression platform that optimizes the production of challenging recombinant proteins.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Salt Lake City, UT, USA

total rounds

2

total raised

$225K
Genovis

Genovis

Genovis provides SmartEnzymes for identification and characterization of antibody based biotherapeutics.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Cambridge, MA, USA

count Of Investments

1
New England Biolabs

New England Biolabs

New England Biolabs is a company that specialises in the discovery and production of enzymes for molecular biology applications.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology

Location

Ipswich, MA, USA
Rapid Novor

Rapid Novor

Rapid Novor Inc. is a leader in antibody protein sequencing technology.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Pharmaceuticals

Location

Kitchener, ON, Canada

total rounds

1

total raised

$5M
M&A Details
1

Acquired by

AbCellera Biologics

announced date

13.09.2021

Financials

Funding Rounds
11
3

Number of Funding Rounds

$8.09M

Money Raised

Their latest funding was raised on 29.09.2020. Their latest round Debt Financing

Date 
Funding Round 
Investors 
Money Raised 
Lead 
29.09.2020
$1.01M
19.07.2018
$809.77K
02.05.2017
1
Co-Investors
Investors
6
4

Number of lead investors

6

Number of investors

Investor 
Lead 
Round 
Partners 
Yes
Venture - Series Unknown
Yes
Venture - Series Unknown
Bill & Melinda Gates Foundation

Bill & Melinda Gates Foundation

The Bill & Melinda Gates Foundation is a philanthropic organization.

Sector

Industrial Support Services

Subsector

Professional Business Support Services

Keywords

Non-Profit

Location

New York, NY, USA

count Of Investments

283

count Of Exists

13
LaunchPad Venture

LaunchPad Venture

Launchpad Venture Group is a Boston-based angel investment and venture capital firm funding early-stage tech companies.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Keywords

Venture Capital, Financial Services, Finance

Location

Newton, MA, USA

count Of Investments

105

count Of Exists

21
Castile Ventures

Castile Ventures

Castile Ventures is a top-performing early-stage venture capital firm.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Keywords

Venture Capital, Financial Services, Banking

Location

Wellesley Hills, Wellesley, MA 02481, USA

count Of Investments

51

count Of Exists

24

People

Founders
1
Bill Gordon
Bill Gordon

Bill Gordon

Bill Gordon is a serial entrepreneur and angel investor. He have been working to spur entrepreneurship in the state of Connecticut since June 2009, when together with Steve Smith and Kip Bergstrom they began to imagine and catalyze the creation of the Stamford Innovation Center at Stamford's Old Town Hall. In the end he chose not be part of the ownership or management of the the Stamford Center itself but was pleased that it finally came to fruition in 2012 as part of the statewide CT Innovation Ecosystem. Andy Moss and he collaborated to participate in the CT Innovation Ecosystem's first year by launching Lean Launch Ventures to run accelerator programs in partnership with CT Innovations, the venture capital arm of the state. They used a Lean Startup curriculum to run the program in the offices Canaan Partners in Westport. In March 2013 They launched our inaugural accelerator program together with CT Innovations supported by a mentor group of over 40 talented individuals from their combined networks. The program ran until the end of June 2013 when they graduated our first class of 5 exciting young companies all on the road to creating new jobs in the State of CT. In September 2013 Bill Gordon joined the graduate faculty of the School of Visual Arts to teach entrepreneurship and leadership together with Karen Proctor to masters level students in the Design for Social Innovation program started by my friend Cheryl Heller. It was a full year course where 7 new companies were built by the second year class that received their MFA degrees in May 2014. We think the combination of collaborative leadership taught in the context of the students' own startup experiences is a unique offer.

current job

Tetragenetics
Tetragenetics

Bill Gordon

Employee Profiles
6
Ashot Papoyan

Ashot Papoyan

Associate Director

R. Douglas Kahn

R. Douglas Kahn

Chairman & CEO

Doug Kahn

Chairman & CEO

Bill Gordon

Bill Gordon

Founder

Activity

Recent News
0